Literature DB >> 3675026

PTFE grafts for hemodialysis access. Techniques for insertion and management of complications.

S Raju1.   

Abstract

In a series of 602 procedures, over 90% of primary forearm insertions of PTFE grafts between the radial artery and a cubital vein were possible. Thrombosis of the graft, which was invariably due to venous outflow obstruction, was the most common complication encountered. Revision of the venous anastomosis was not necessary in about one-third of the thrombosed grafts if a size 3 coronary dilator could be passed and the augmentation test was satisfactory. For revisions, creation of a new venous anastomosis using a jump graft was preferred over patch angioplasty or venous endarterectomy. Crossing the elbow for this purpose did not adversely affect graft patency. The incidence of aneurysm formation and infection was 16% and 35%, respectively. Infections involving the graft were managed by drainage, antibiotics, and bypass of the infected portion. Immediate bypass and delayed bypass were equally effective. About one-half of the infected grafts were salvaged by these techniques. The most common organism was Staphylococcus aureus. With a combination of the techniques outlined above, the service life of individual PTFE grafts can be extended. Two-year access patency in this series was 77%.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3675026      PMCID: PMC1493291          DOI: 10.1097/00000658-198711000-00019

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  10 in total

1.  Vascular access for haemodialysis--experience at Johannesburg Hospital.

Authors:  G Louridas; J R Botha; L Levien; F J Milne; A M Meyers; J A Myburgh
Journal:  S Afr Med J       Date:  1984-10-27

2.  Arteriovenous access for hemodialysis: utilizing polytetrafluoroethylene grafts.

Authors:  A H Mohaideen; S Tanchajja; M M Avram; R A Mainzer
Journal:  N Y State J Med       Date:  1980-02

3.  Vascular access complications and new methods.

Authors:  F J Veith; S E Wilson; R W Hobson; J J Rosenthal; V A Tellis; F J Dagher
Journal:  Trans Am Soc Artif Intern Organs       Date:  1982

4.  Vascular access for hemodialysis. Patency rates and results of revision.

Authors:  S B Palder; R L Kirkman; A D Whittemore; R M Hakim; J M Lazarus; N L Tilney
Journal:  Ann Surg       Date:  1985-08       Impact factor: 12.969

5.  Management of sepsis involving expanded polytetrafluoroethylene grafts for hemodialysis access.

Authors:  D J Bhat; V A Tellis; W I Kohlberg; B Driscoll; F J Veith
Journal:  Surgery       Date:  1980-04       Impact factor: 3.982

6.  Polytetrafluoroethylene graft survival in hemodialysis.

Authors:  R Munda; M R First; J W Alexander; C C Linnemann; J P Fidler; D Kittur
Journal:  JAMA       Date:  1983-01-14       Impact factor: 56.272

7.  Medium-term follow-up of forty autogenous vein and forty polytetrafluoroethylene (Gore-Tex) grafts for vascular access.

Authors:  A M Jenkins; T A Buist; S D Glover
Journal:  Surgery       Date:  1980-11       Impact factor: 3.982

8.  Complications of vascular access for hemodialysis.

Authors:  O E Winsett; F J Wolma
Journal:  South Med J       Date:  1985-05       Impact factor: 0.954

9.  Polytetrafluoroethylene (PTFE) grafts for haemodialysis in chronic renal failure: assessment of durability and function at three years.

Authors:  A Rapaport; G P Noon; C H McCollum
Journal:  Aust N Z J Surg       Date:  1981-12

10.  Complications of renal dialysis access procedures.

Authors:  J E Connolly; D A Brownell; E F Levine; P M McCart
Journal:  Arch Surg       Date:  1984-11
  10 in total
  8 in total

1.  Local thrombolysis and thromboaspiration in the treatment of acutely thrombosed arteriovenous hemodialysis fistulas.

Authors:  F Poulain; A Raynaud; P Bourquelot; C Knight; X Rovani; J C Gaux
Journal:  Cardiovasc Intervent Radiol       Date:  1991 Mar-Apr       Impact factor: 2.740

Review 2.  Complications of the Arteriovenous Fistula: A Systematic Review.

Authors:  Ahmed A Al-Jaishi; Aiden R Liu; Charmaine E Lok; Joyce C Zhang; Louise M Moist
Journal:  J Am Soc Nephrol       Date:  2016-12-28       Impact factor: 10.121

Review 3.  Definitions and End Points for Interventional Studies for Arteriovenous Dialysis Access.

Authors:  Gerald A Beathard; Charmaine E Lok; Marc H Glickman; Ahmed A Al-Jaishi; Donna Bednarski; David L Cull; Jeffery H Lawson; Timmy C Lee; Vandana D Niyyar; Donna Syracuse; Scott O Trerotola; Prabir Roy-Chaudhury; Surendra Shenoy; Margo Underwood; Haimanot Wasse; Karen Woo; Theodore H Yuo; Thomas S Huber
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-20       Impact factor: 8.237

4.  Use of enoxaparin to diminish the incidence of vascular access stenosis/thrombosis in chronic hemodialysis patients.

Authors:  Linda Shavit; Meyer Lifschitz; Shuko Lee; Itzchak Slotki
Journal:  Int Urol Nephrol       Date:  2010-01-10       Impact factor: 2.370

5.  A prospective evaluation of plasma-TFE and expanded PTFE grafts for routine and early use as vascular access during hemodialysis.

Authors:  T S Helling; P W Nelson; L Shelton
Journal:  Ann Surg       Date:  1992-11       Impact factor: 12.969

6.  You Can Do That? Performing Total Recanalization of Completely Stented Arterial-venous Grafts.

Authors:  Taylor S Harmon; Travis E Meyer; Jerry Matteo
Journal:  Cureus       Date:  2018-10-01

7.  Timing of the first cannulation and survival of arteriovenous grafts in hemodialysis patients: a multicenter retrospective cohort study.

Authors:  Su-Ju Lin; Shu-Chen Chang; Chun-Wu Tung; Yung-Chien Hsu; Ya-Hsueh Shih; Yi-Ling Wu; Tse-Chih Chou; Chun-Liang Lin
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

8.  Mechanically reinforced biotubes for arterial replacement and arteriovenous grafting inspired by architectural engineering.

Authors:  Dengke Zhi; Quhan Cheng; Adam C Midgley; Qiuying Zhang; Tingting Wei; Yi Li; Ting Wang; Tengzhi Ma; Muhammad Rafique; Shuang Xia; Yuejuan Cao; Yangchun Li; Jing Li; Yongzhe Che; Meifeng Zhu; Kai Wang; Deling Kong
Journal:  Sci Adv       Date:  2022-03-16       Impact factor: 14.136

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.